Predicting multi-vascular diseases in patients with coronary artery disease

Suko Adiarto1, Luthfian Aby Nurachman2, Raditya Dewangga3

  • 1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.

F1000Research
|September 25, 2023
PubMed

Insights

A new predictive model identifies high-risk coronary artery disease patients for multi-vascular disease screening. This targeted approach significantly reduces the number needed to screen, improving efficiency and specificity.

Area of Science:

  • Cardiovascular Medicine
  • Medical Diagnostics
  • Public Health Screening

Background:

  • Coronary artery disease (CAD) indicates systemic atherosclerosis, posing risks for other vascular diseases.
  • Current screening for multi-vascular disease in CAD patients is ineffective.
  • Risk factors for multi-vascular disease in CAD patients remain understudied.

Purpose of the Study:

  • To develop a predictive model and scoring system for targeted multi-vascular disease screening in CAD patients.
  • To identify key risk factors associated with multi-vascular disease in this population.

Main Methods:

  • Cross-sectional study of CAD patients diagnosed via coronary angiography or PCI.
  • Diagnosis of coronary artery stenosis (CAS), abdominal aortic aneurysm (AAA), and peripheral artery disease (PAD) using Doppler ultrasound and ABI score.
  • Multivariate logistic regression for model construction and risk score calculation, validated with ROC analysis and Hosmer-Lemeshow test.

Main Results:

  • Age >60, diabetes mellitus, cerebrovascular disease, and CAD with 3-vessel disease (CAD3VD) were significant predictors of multi-vascular disease.
  • The predictive model showed good capability (AUC = 0.659) and calibration (Hosmer-Lemeshow p = 0.379).
  • Targeted screening reduced the number needed to screen (NNS) from 6 to 3, with 96.5% specificity.

Conclusions:

  • A clinical risk score-based targeted screening strategy is effective for multi-vascular disease in CAD patients.
  • This approach enhances screening efficiency by decreasing the NNS.
  • The model offers good predictive capability and high specificity for identifying at-risk individuals.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9